Dimitrios Kapogiannis is a Behavioral Neurologist and Clinician-Scientist who specializes in Alzheimer’s disease. He acquired his Medical Degree from the University of Athens Medical School, completed a Neurology residency training program at the Massachusetts General Hospital/Brigham and Women’s Hospital/Harvard Medical School, and a Clinical Fellowship in Behavioral Neurology at the National Institute of Neurological Disorders and Stroke. He has been a Clinical Investigator at the National Institute on Aging conducting clinical and translational studies in Alzheimer's disease since 2014. He is also conducting clinical trials of metabolism-based interventions for Alzheimer’s disease prevention. He holds an adjunct appointment as Associate Professor at the Department of Neurology of Johns Hopkins University and provides clinical care at the Johns Hopkins Memory and Alzheimer's Treatment Center. Dr. Kapogiannis has authored more than 100 peer-reviewed publications. He is also member of the Editorial Boards of "Ageing Research Reviews", "npj Aging and Mechanisms of Disease" and “Cells”. Dr. Kapogiannis is widely recognized as an expert in the field of Extracellular Vesicle biomarkers and has pioneered the use of neuronal-enriched Extracellular Vesicles for the clinical and preclinical diagnosis of Alzheimer’s disease and other neurodegenerative, neurological and psychiatric diseases.